Kwanghee J. Kim

Internal Medicine

3831 Piper Street
S Tower, Suite S-220
Anchorage, AK 99508

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 40 publications

Induction and characterization of neoplastic bladder tumors in a transgenic porcine model.

Induction and characterization of neoplastic bladder tumors in a transgenic porcine model.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: November 21, 2025

Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model.

Synergistic Efficacy of WST11-VTP and P-Selectin-Targeted Nanotherapy in a Preclinical Prostate Cancer Model.

Journal: Cancers

Published: June 03, 2025

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Determinants of sensitivity to HER2-targeted antibody drug conjugates in urothelial cancer.

Journal: Nature communications

Published: May 07, 2025

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.

Neoadjuvant Chemotherapy for High-risk Localized Upper Tract Urothelial Carcinoma: Final Long-term Outcomes from a Phase 2 Clinical Trial and an Expanded Cohort.

Journal: European urology

Published: April 22, 2025

Feasibility and Pathologic Outcomes of Peripheral Lung Vascular Targeted Photodynamic Therapy in a Normal Porcine Lung Model.

Feasibility and Pathologic Outcomes of Peripheral Lung Vascular Targeted Photodynamic Therapy in a Normal Porcine Lung Model.

Journal: CHEST pulmonary

Published: August 29, 2024

Selectivity and anti-tumor immune elevation by vascular-targeted photodynamic therapy of mouse orthotopic bladder cancer model.

Selectivity and anti-tumor immune elevation by vascular-targeted photodynamic therapy of mouse orthotopic bladder cancer model.

Journal: Photochemistry and photobiology

Published: August 22, 2024

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.

Molecular Heterogeneity and Immune Infiltration Drive Clinical Outcomes in Upper Tract Urothelial Carcinoma.

Journal: European urology

Published: June 02, 2024

Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model.

Comparative study of immune response to local tumor destruction modalities in a murine breast cancer model.

Journal: Frontiers in oncology

Published: March 22, 2024

Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma.

Feasibility and tissue concordance of genomic sequencing of urinary cytology in upper tract urothelial carcinoma.

Journal: Urologic oncology

Published: June 14, 2023

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma.

Final Results of a Phase I Trial of WST-11 (TOOKAD Soluble) Vascular-targeted Photodynamic Therapy for Upper Tract Urothelial Carcinoma.

Journal: The Journal of urology

Published: February 01, 2023

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 05, 2023

Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.

Journal: Nature communications

Published: December 23, 2022

Showing 1-12 of 40

Last Updated: 09/26/2026